MENU
LEXX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexaria Bioscience (LEXX) Ownership - Who owns Lexaria Bioscience?
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more
Profile
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.64M
P/E Ratio
N/A
Total Cash
6.54M
Projected Growth
N/A
Total Debt
123.72K
Revenue
525.92K
Risk (Beta)
0.79
Dividend Yield
N/A
Total Cash/Share
0.37
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
LEXX
Capitalization
25.6M
P/E Ratio
N/A
Risk (Beta)
0.79
Dividend Yield
N/A
Total Cash
6.54M
Total Cash/Share
0.37
Total Debt
124K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
526K
ROE
N/A
Book Value
7.15M
P/B Ratio
3.59
Cash Flow
N/A
Earnings
-0.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.6K
Current Ratio
4.24
Current Revenue Per Employee
24857.14
Dividends Per Share - Security
N/A
EBITDA
-9.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-124.87
Shares Held By Institutions
3.42M
Shares Outstanding - Current
17.6M
Total Liabilities
1.92M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-30.476
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com